LUGENE ANALYTICS - Trademark Details
Status: 641 - Non-Final Action - Mailed
Serial Number
90340575
Word Mark
LUGENE ANALYTICS
Status
641 - Non-Final Action - Mailed
Status Date
2021-12-10
Filing Date
2020-11-24
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
DOMBROW, COLLEEN M
Statements
Disclaimer with Predetermined Text
"ANALYTICS"
Goods and Services
Medical information services, namely, providing information relating to the suitability of patients for clinical trials based on their genetic profiles and gene expression; providing information relating to the best drug options for individuals with autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases based on their genetic profile and gene expression
Goods and Services
Providing temporary use of non-downloadable computer software applications for grouping and categorizing human genes according to their biological function, analyzing the role of genes in promoting or inhibiting disease activity associated with autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases and scoring such genes based on their role in promoting or inhibiting such disease activity, identifying blood and non-blood cells within the gene sequences contained in human tissues and organs, and analyzing genes and genetic profiles to assess disease activity in patients suffering from autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases, and assessing the efficacy of pharmaceuticals, drug therapies and treatments to treat such diseases
Goods and Services
Medical information services, namely, providing medical information relating to the suitability of patients for clinical trials based on their genetic profiles and gene expression; providing medical information relating to the best drug options for individuals with autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases based on their genetic profile and gene expression
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-01-30
Primary Code
042
First Use Anywhere Date
2018-10-29
First Use In Commerce Date
2018-10-29
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-11-12
Primary Code
044
First Use Anywhere Date
2018-10-29
First Use In Commerce Date
2018-10-29
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Patrick C. Asplin
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2020-11-27 | NEW APPLICATION ENTERED IN TRAM |
| 2021-01-30 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2021-05-07 | ASSIGNED TO EXAMINER |
| 2021-05-11 | NON-FINAL ACTION WRITTEN |
| 2021-05-11 | NON-FINAL ACTION E-MAILED |
| 2021-05-11 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-11-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-11-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-11-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-12-10 | NON-FINAL ACTION WRITTEN |
| 2021-12-10 | NON-FINAL ACTION E-MAILED |
| 2021-12-10 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
